Clinical characteristics and outcomes in HIV-associated diffuse large B-cell lymphoma in China: A retrospective single-center study - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33854591/
Human immunodeficiency virus (HIV) infection is associated with an increased risk of aggressive lymphoma, especially diffuse large B cell lymphoma (DLBCL). There are few data regarding HIV-associated DLBCL in China....
-
Mark Fesler4yrNice characterization of a reasonably common clinical entity in a populous country
Composite lymphoma of T-cell rich, histiocyte-rich diffuse large B-cell lymphoma and nodular lymphocyte predominant Hodgkin lymphoma: a case report - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33849639/
doi: 10.1186/s13256-021-02783-9. 1 Neurology department, Tishreen University hospital, Lattakia, Syria. [email protected]. 2 Faculty of Medicine, Damascus University, Damascus, Syria. 3 Pathology department, Tishreen University hospital, Lattakia, Syria. Free PMC article...
-
Mark Fesler4yrFascinating... these two diseases are often confused histologically. Impressive work on pathology’s part to recognize two separate but related entities
Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33842331/
Cancers, including lymphomas, develop in complex tissue environments where malignant cells actively promote the creation of a pro-tumoral niche that suppresses effective anti-tumor effector T cell responses. Research is revealing...
-
Mark Fesler4yrStudy inches closer at finding predictive factors for immune therapy responsiveness , a big unmet need in lymphoma
Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33845778/
doi: 10.1186/s12872-021-01996-6. 1 Department of Diagnostic Imaging, Universidade Federal de São Paulo (UNIFESP), Rua Napoleão de Barros 800, Vila Clementino, São Paulo, 04024-002, Brazil. [email protected]. 2 Department of Tropical Diseases...
-
Mark Fesler4yrInteresting study focusing on an important problem for a wide range of lymphoma patients receiving anthracycline chemotherapy
Perspectives on outpatient administration of CAR-T cell therapy in aggressive B-cell lymphoma and acute lymphoblastic leukemia - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33846220/
Chimeric antigen receptor (CAR) T-cell therapies that specifically target the CD19 antigen have emerged as a highly effective treatment option in patients with refractory B-cell hematological malignancies. Safety and efficacy...
-
DLBCL Connect4yrKey Points • In patients diagnosed with refractory B-cell hematological malignancies, chimeric antigen receptor (CAR) T-cell therapies that target the CD19 antigen have proven highly effective. CAR T-cell therapies work in patients Show More